Search Results - "Sithabiso D. Masuku"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    The costs of interventions for type 2 diabetes mellitus, hypertension and cardiovascular disease in South Africa - a systematic literature review

    The costs of interventions for type 2 diabetes mellitus, hypertension and cardiovascular disease in South Africa - a systematic literature review by Masuku, Sithabiso D, Lekodeba, Nkgomeleng, Meyer-Rath, Gesine

    Published in BMC public health (12-12-2022)
    “…In the context of a move to universal health coverage, three separate systematic reviews were conducted to summarise available evidence on the direct costs of…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    The cost of adding rapid screening for diabetes, hypertension, and COVID-19 to COVID-19 vaccination queues in Johannesburg, South Africa

    The cost of adding rapid screening for diabetes, hypertension, and COVID-19 to COVID-19 vaccination queues in Johannesburg, South Africa by Masuku, Sithabiso D, Brennan, Alana T, Vetter, Beatrice, Venter, Francois, Mtshazo, Bukelwa, Sokhela, Simiso, Mashabane, Nkuli, Kao, Kekeletso, Meyer-Rath, Gesine

    Published in BMC public health (16-07-2024)
    “…Non-communicable diseases (NCDs) are responsible for 51% of total mortality in South Africa, with a rising burden of hypertension (HTN) and diabetes mellitus…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Integration of point-of-care screening for type 2 diabetes mellitus and hypertension into the COVID-19 vaccine programme in Johannesburg, South Africa

    Integration of point-of-care screening for type 2 diabetes mellitus and hypertension into the COVID-19 vaccine programme in Johannesburg, South Africa by Brennan, Alana T, Vetter, Beatrice, Masuku, Sithabiso D, Mtshazo, Bukelwa, Mashabane, Nkuli, Sokhela, Simiso, Venter, Willem Df, Kao, Kekeletso, Meyer-Rath, Gesine

    Published in BMC public health (20-11-2023)
    “…South Africa grapples with a substantial burden of non-communicable diseases (NCDs), particularly type 2 diabetes (diabetes) and hypertension. However, these…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Costs and cost-effectiveness of treatment setting for children with wasting, oedema and growth failure/faltering: A systematic review

    Costs and cost-effectiveness of treatment setting for children with wasting, oedema and growth failure/faltering: A systematic review by Mdege, Noreen Dadirai, Masuku, Sithabiso D, Musakwa, Nozipho, Chisala, Mphatso, Tingum, Ernest Ngeh, Boachie, Micheal Kofi, Shokraneh, Farhad

    Published in PLOS global public health (2023)
    “…This systematic review aimed to address the existing evidence gaps, and guide policy decisions on the settings within which to treat infants <12 months of age…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    Costs and cost-effectiveness of treatment setting for children with wasting, oedema and growth failure/faltering: A systematic review

    Costs and cost-effectiveness of treatment setting for children with wasting, oedema and growth failure/faltering: A systematic review by Noreen Dadirai Mdege, Sithabiso D. Masuku, Nozipho Musakwa, Mphatso Chisala, Ernest Ngeh Tingum, Micheal Kofi Boachie, Farhad Shokraneh

    Published in PLOS global public health (01-01-2023)
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: